Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 6/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.41 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ATP2A2 | P16615 | 1/20 | 0.39 |
| ▸ | ATP2A3 | Q93084 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15957658 | 0.87 | AR (0.44) | ALDH1A1SMN1; SMN2ARCYP1A2HSP90AA1 | |
| SCHEMBL17286707 | 0.86 | ALOX15 (0.41) | ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4 | |
| SCHEMBL17286715 | 0.85 | ALDH1A1 (0.44) | ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4 | |
| SCHEMBL15957891 | 0.81 | SMN1; SMN2 (0.44) | ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4 | |
| SCHEMBL17286714 | 0.79 | ALOX15 (0.44) | ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4 | |
| SCHEMBL20934761 | 0.79 | AR (0.40) | SMN1; SMN2ARHSP90AA1HSD11B1PGK1 | |
| SCHEMBL15957675 | 0.78 | SMN1; SMN2 (0.42) | ALDH1A1SMN1; SMN2CYP3A4MAPK1TSHR | |
| SCHEMBL15957692 | 0.78 | AR (0.39) | ALOX15ALDH1A1SMN1; SMN2TP53CYP3A4 | |
| SCHEMBL15831663 | 0.76 | PGK1 (0.47) | SMN1; SMN2ARCYP1A2HSP90AA1CYP2C9 | |
| SCHEMBL12197682 | 0.75 | ALDH1A1 (0.47) | ALOX15ALDH1A1SMN1; SMN2TSHRAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9464163-B2 | Novolak resin containing hexafluoroisopropanol group, method for producing same, and composition of same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2016-10-11 | — | — | US | disclosed |
| US-20150337077-A1 | Novolak Resin Containing Hexafluoroisopropanol Group, Method for Producing Same, and Composition of Same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2015-11-26 | — | — | US | disclosed |
| US-8809451-B2 | Fluorinated dicarboxylic acid derivative and polymer obtained therefrom | CENTRAL GLASS COMPANY, LIMITED (JP) | 2014-08-19 | — | — | US | disclosed |
| US-20110301305-A1 | Fluorinated Dicarboxylic Acid Derivative and Polymer Obtained Therefrom | CENTRAL GLASS COMPANY, LIMITED (JP) | 2011-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110301305-A1 | Fluorinated Dicarboxylic Acid Derivative and Polymer Obtained Therefrom | MCCC2, AFF2, F13A1 | ALOX15 616/4885ALDH1A1 181/4885SMN1; SMN2 3546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.